Roche/GSK Boniva Launch Plan Includes Reminders For Once-Monthly Dose
Roche and GlaxoSmithKline will support the launch of the osteoporosis therapy Boniva (ibandronate) with a program intended to help patients comply with the once-monthly oral dosing regimen